RÉACTIFS DE LIAISON DE LA PROTÉINE MEMBRANAIRE ÉPITHÉLIALE 2 (EMP2) ET LEURS UTILISATIONS THÉRAPEUTIQUES DANS DES MALADIES OCULAIRES

• 收藏
• 分享

专利权人:

UNITED STATES GOVERNMENT DEPARTMENT OF VETERANS AFFAIRS;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

发明人:

GORDON, LYNN K.,BRAUN, JONATHAN,MORALES, SHAWN,TELANDER, DAVID, G.,WADEHRA, MADHURI

申请号：

EP11745457

公开号：

EP2536433A4

申请日:

2011.02.22

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

A method is disclosed for treating diseases or disorders of the eye involving undesired expression of vascular endothelial growth factor (VEGF) by administration of endothelial membrane protein 2 (EMP2) inhibitor. The present invention relates to the direct treatment of macular degeneration, particularly age-related macular degeneration (AMD), by administering an EMP2 inhibitor intraocularly or systemically.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/